The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Furmonertinib as adjuvant therapy in postoperative EGFR-mutated stage IA2-IIIA non-small cell lung cancer (NSCLC) with high-risk pathological factors.
 
Ziheng Wu
No Relationships to Disclose
 
Qingyi Zhang
No Relationships to Disclose
 
Lei Ke
No Relationships to Disclose
 
Tianyu He
No Relationships to Disclose
 
Wang Lv
No Relationships to Disclose
 
Jian Hu
No Relationships to Disclose